Respiratory failure & ventilation

Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials

Crit Care MedPublished Secondary analysis of two randomised controlled trials

Authors' conclusion

Plasma IL-18 level provides important additional prognostic information to LCA subphenotypes defined largely by traditional inflammatory biomarkers in two large ARDS cohorts.

Study context

Population
Acute respiratory distress syndrome (ARDS) patients in two multicentre RCTs
Participants
683 vs 511
Comparison
High IL-18 vs low IL-18 within the hypoinflammatory LCA class
  • SAILSn = 683
  • HARP-2n = 511
Primary endpoint
Association of IL-18 level with mortality in the hypoinflammatory LCA class
Follow-up
60 days
Methodological detailsSAILS and HARP-2, retrospective, multicentre
  • SAILS and HARP-2
  • Retrospective
  • Multicentre

Primary result

As reported in the abstract

60-d mortality in hypoinflammatory LCA patients with elevated IL-18
Odds ratio (95% CI)P value
SAILS
3.3(1.8–6.1)
P < 0.001
HARP-2
2.1(1.2–3.8)
P = 0.009
Hypoinflammatory by LCA but high risk by elevated IL-18, SAILS
14%
Hypoinflammatory by LCA but high risk by elevated IL-18, HARP-2
43%

Further findings

Discordance between IL-18 level and LCA class

Patients discordant by IL-18 level and LCA class (SAILS and HARP-2)
33%

Correlation of IL-18 with LCA cytokines

Only modest correlation
0.17-0.47

Original publication

Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials. Crit Care Med. Published 11 September 2023. doi:10.1097/ccm.0000000000006028

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.